Sector breakdown

04
Healthcare 100.0%

Full portfolio 3 positions

05
Type Streak 8Q trend
BEAM Beam Therapeutics Inc. - Common Stock $55,018,488 67.66% 2,266,934 $16,457,941
LYEL Lyell Immunopharma, Inc. - Common Stock $16,371,804 20.13% 1,008,116 Up ×1
PRME Prime Medicine, Inc. - Common Stock $9,928,843 12.21% 1,792,210 $5,502,084

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
LYEL $16,371,804 1,008,116 20.13%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
BEAM Price move only +0 +$16.5M
PRME Price move only +0 +$5.5M

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
LYEL (filed as LYELXXXX) Sept. 30, 2025 1,008,116 $8,911,745 -43.0%